Tempus AI, Inc. (TEM)

Market Cap	10.11B +21.1%
Revenue (ttm)	1.27B +83.4%
Net Income	-245.03M
EPS	-1.41
Shares Out	179.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,363,260
Open	50.35
Previous Close	49.53
Day's Range	50.35 - 56.50
52-Week Range	39.01 - 104.32
Beta	n/a
Analysts	Buy
Price Target	72.83 (+29.11%)
Earnings Date	May 5, 2026

About TEM

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sc...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 14, 2024
• Employees: 3,800
• Stock Exchange: NASDAQ
• Ticker Symbol: TEM
• Website: https://www.tempus.com

Financial Performance

In 2025, Tempus AI's revenue was $1.27 billion, an increase of 83.41% compared to the previous year's $693.40 million. Losses were -$245.03 million, -67.12% less than in 2024.

Analyst Summary

According to 12 analysts, the average rating for TEM stock is "Buy." The 12-month stock price target is $72.83, which is an increase of 29.11% from the latest price.

Price Target

$72.83

(29.11% upside)

Analyst Consensus: Buy